ClearPoint Neuro Profit Margin

The latest profit margin for CLPT is -81.76% as of June 2026. That compares with -66.15% in the prior-year period — down 23.6% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside ClearPoint Neuro's historical trend and sector peers before judging valuation or financial health.

Over the past year, CLPT's profit margin moved from -66.15% to -81.76% — a 23.6% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in ClearPoint Neuro's valuation or profitability profile.

Against Healthcare companies, CLPT currently prints -81.76% for profit margin, while the sector average sits near 13.89%. That is roughly 688.5% below the sector mean. Large gaps often invite a closer look at ClearPoint Neuro's growth, margins, and balance sheet.

Profit Margin shows how effectively ClearPoint Neuro converts resources into returns. At -81.76%, CLPT may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -66.15% in the prior-year period — down 23.6% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting CLPT's profit margin (-81.76%), review year-over-year change from -66.15%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.